Introducing ARCEX
The first system approved for non-invasive spinal cord stimulation for people with spinal cord injury (SCI).
Read the Evidence
The results from our Up-LIFT pivotal trial were published in Nature Medicine, one of the world’s preeminent scientific journals.
The Up-LIFT study evaluated the safety and effectiveness of non-invasive electrical spinal cord stimulation (ARCEX Therapy) to improve hand sensation and strength in people with chronic incomplete tetraplegia. The clinical study enrolled 65 people at 14 leading SCI centers in the US, Europe, and Canada.
Highlights* include:
-Primary safety and effectiveness endpoints met.
-90% of participants improved strength or function of their upper limbs.
-Upper extremity sensory scores improved significantly with device use.
-87% of participants reported improvement in quality of life.
-Improvement was demonstrated in participants up to 34 years post-injury.
Discover what ARCEX Does
The ARCEX System is indicated to improve hand sensation and strength for people with a chronic cervical spinal cord injury.**
The system is comprised of a Stimulator that delivers electrical pulses to the cervical spinal cord via Electrodes placed on the skin at the back of the neck.
ARCEX can be used in the clinic to enable personalized functional rehabilitation.
Discover what ARCEX Does
The ARCEX System is indicated to improve hand sensation and strength for people with a chronic cervical spinal cord injury.**
The system is comprised of a Stimulator that delivers electrical pulses to the cervical spinal cord via Electrodes placed on the skin at the back of the neck.
ARCEX can be used in the clinic to enable personalized functional rehabilitation.
Locate the resources
you may need
View our Media Coverage
-
FDA clears game-changing new spinal cord injury device
ABC News
-
ONWARD wins FDA nod for non-invasive spinal cord stim
Mass Device
-
FDA OKs novel device for non-invasive treatment of spinal cord injuries
STAT
-
Parkinson’s implant restores man’s ability to walk
BBC
-
AI implants help paralyzed patient move arms, hands
CNN This Morning
-
Miracle steps: Spinal cord implant brings hope, mobility to Parkinson’s patient
USA Today
“When we talk about 10% more function, we think about how important that is in terms of being able to live a life. That little bit more independence allows you to do so much more.”
Jessie Owen
Note: Patient testimonials reflect individual experiences and outcomes, which may vary. Please review the full product label and clinical study data.
Explore our Blog
Find the answers to
Frequently Asked Questions
The ONWARD® Medical ARCEX® System is cleared for use only in the United States.
*Moritz, Chet, et al. “Non-invasive spinal cord stimulation for arm and hand function in chronic tetraplegia: a safety and efficacy trial.” Nature Medicine. 2024.
**The ARCEX System is intended to deliver programmed, transcutaneous electrical spinal cord stimulation in conjunction with functional task practice in the clinic to improve hand sensation and strength in individuals between 18 and 75 years old that present with a chronic, non-progressive neurological deficit resulting from an incomplete spinal cord injury (C2-C8 inclusive).